BPC 157 helps resolve this problem by triggering a process known as angiogenesis. This can be the physiological course of action by which new blood vessels kind from pre-existing vessels. The peptide activates the VEGFR2 pathway (Vascular Endothelial Growth Factor Receptor two), which effectively tells the human body to make new capillary networks